According to a new report Global Stroke Management Market, published by KBV research, The Global Stroke Management Market size is expected to reach $40.6 billion by 2024, rising at a market growth of 7.3% CAGR during the forecast period.
The North America market would dominate the Global Diagnostics Stroke Management Market by Region by 2024, growing at a CAGR of 6.2 % during the forecast period. The Europe market is expected to witness a CAGR of 6.1% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 7.6% during (2018 - 2024).
The Ischemic Stroke market dominated the Global Stroke Management Market by Application 2017, and would achieve a market value of $25,784.1 million by 2024, growing at a CAGR of 5.7 % during the forecast period. The Hemorrhagic Stroke market is expected to witness a CAGR of 10.6% during (2018 - 2024).
Full Report: https://www.kbvresearch.com/stroke-management-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.
By Type
By Application
By Geography
Companies Profiled
Unique Offerings from KBV Research
Related Reports:
North America Stroke Management Market
Europe Stroke Management Market
Asia Pacific Stroke Management Market
LAMEA Stroke Management Market
Unique Offerings 
